A detailed history of Garner Asset Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Garner Asset Management Corp holds 520 shares of LLY stock, worth $413,748. This represents 0.2% of its overall portfolio holdings.

Number of Shares
520
Previous 540 3.7%
Holding current value
$413,748
Previous $489,000 5.73%
% of portfolio
0.2%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $15,442 - $19,200
-20 Reduced 3.7%
520 $461,000
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $23,633 - $27,860
-45 Reduced 7.69%
540 $314,000
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $8,694 - $11,986
-20 Reduced 3.31%
585 $314,000
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $7,014 - $9,379
-20 Reduced 3.2%
605 $284,000
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $194,143 - $228,012
625 New
625 $215,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Garner Asset Management Corp Portfolio

Follow Garner Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garner Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Garner Asset Management Corp with notifications on news.